Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
Perirenal hematomas in 8 patients on dialysis therapy
Shiko Gen, Tsutomu Inoue, Takaya Sasaki, Kanako Nobe, Kanako Saito, Mika Okayama, Takeru Seto, Naofumi Ikeda, Hiromichi Suzuki
Author information
JOURNAL FREE ACCESS

2015 Volume 48 Issue 3 Pages 193-198

Details
Abstract
Perirenal hematoma is an uncommon disease caused by trauma, neoplastic disease, renal cyst infection, or other factors. It is sometimes caused by anticoagulant or antiplatelet agents and occasionally occurs in patients on dialysis therapy. When considering the etiology of perirenal hematoma in dialysis patients, acquired cystic disease of the kidney (ACDK) may be an important factor, as all eight patients whom we treated had ACDK. Five of these eight patients had no past history of calculi, neoplastic lesions, or trauma, and perirenal hematoma in these five was associated with rupture of ACDK. Six of the patients with hematoma were peritoneal dialysis patients, and their drained dialysis solutions were all hemorrhagic, suggesting that perirenal hematoma should be considered in the differential diagnosis when bloody drainage is seen in peritoneal dialysis patients. The incidence of ACDK-associated perirenal hematoma is likely to increase with the growing number of long-term dialysis patients. If dialysis patients suddenly complain of lower back pain or if bloody drainage is seen in peritoneal dialysis patients, perirenal hematoma should be considered, and the patient should be subjected to close monitoring. Therapeutic regimens should be established with appropriate consideration of the progression of anemia, the patient's systemic condition, and potential complications of renal cell carcinoma.
Content from these authors
© 2015 The Japanese Society for Dialysis Therapy
Previous article Next article
feedback
Top